Priapism in Sickle Cell Disease
Priapism in Sickle Cell Disease
1. Introduction & Pathophysiology
Priapism is a persistent, often painful, penile erection unrelated to sexual stimulation. In SCD, it is almost exclusively ischemic (low-flow) priapism, a urological emergency.
- Mechanism: Sickled red blood cells cause veno-occlusion within the corpora cavernosa. This leads to stasis, hypoxia, acidosis, and further sickling in a vicious cycle. If not relieved promptly (within 4-6 hours), it can result in irreversible fibrosis and permanent erectile dysfunction.
Priapism is classified by duration:
- Stuttering (Recurrent Acute): Brief, intermittent episodes that resolve spontaneously.
- Acute (Prolonged): An erection lasting >4 hours, requiring emergency intervention.
2. Medications and Interventions to AVOID
This is a critical component of management. Using the wrong therapy can exacerbate the condition.
| Medication/Intervention | Reason to Avoid |
|---|---|
| Intracavernosal Therapies for Erectile Dysfunction | This is a common cause of iatrogenic priapism. Agents like alprostadil, papaverine, and phentolamine are absolutely contraindicated in patients with SCD due to their high risk of triggering prolonged episodes. |
| Oral Phosphodiesterase-5 (PDE5) Inhibitors (e.g., Sildenafil, Tadalafil) | These drugs can precipitate or worsen priapism in susceptible individuals like those with SCD. They are contraindicated for the treatment of erectile dysfunction in SCD patients with a history of priapism. |
| Alpha-Adrenergic Antagonists (Alpha-Blockers) (e.g., Tamsulosin, Doxazosin) | While sometimes used preventatively in other contexts, they can precipitate priapism and should be used with extreme caution, if at all, in SCD patients. |
| Anticoagulants & Antiplatelets (e.g., Heparin, Clopidogrel) | Not first-line and not indicated for the acute management of ischemic priapism. There is no evidence of benefit, and they increase the risk of bleeding, especially if surgical intervention is required. |
| Ice Packs / Cold Compresses | Can theoretically worsen vasoconstriction and stasis, although evidence is limited. Warm compresses are generally preferred to promote vasodilation and blood flow. |
| Delaying Definitive Treatment | The most dangerous “intervention to avoid” is inaction. Aspiration and irrigation should not be delayed while waiting for medical therapies (like hydration and analgesia) to work if the priapism is prolonged. |
3. Suitable Management Options (Based on NICE NG239 & RCEMlearning)
Management is a step-wise progression based on the duration of the episode and response to therapy.
A. First-Line & Supportive Care (All Patients)
- Rapid Assessment & Pain Control:
- Analgesia: Administer strong, prompt analgesia. Opioids (e.g., Morphine) are often required. NSAIDs can be used adjunctively but are insufficient alone.
- Hydration: Initiate intravenous fluid therapy (e.g., 0.9% Sodium Chloride) to help reduce sickling.
- Concurrent Sickle Cell Crisis Management:
- Assess for and manage any other features of a vaso-occlusive crisis (VOC).
- Consider Transfusion: Simple top-up transfusion may be considered if the patient is anaemic. Exchange transfusion is rarely needed in the acute setting and carries a risk of hyperviscosity; it should only be considered in severe, refractory cases in consultation with a haematologist.
B. Specific Urological Interventions (Time-Dependent)
The following ladder of intervention should be followed, escalating if there is no response. The key determinant is time since onset.
| Step | Intervention | Description & Rationale | When to Use |
|---|---|---|---|
| 1 | Corporal Aspiration & Irrigation | After local anaesthetic, a butterfly needle is inserted into the corpora cavernosa. Aspiration of dark, deoxygenated blood confirms the diagnosis. This is followed by irrigation with 0.9% saline. | First-line invasive procedure for any episode lasting >4 hours. It decompresses the corpora, relieves pressure, and washes out sickled cells and acidic metabolites. |
| 2 | Intracavernosal Sympathomimetics | If aspiration alone is insufficient, the next step is irrigation with an alpha-adrenergic agonist. Phenylephrine is the agent of choice due to its relative selectivity for alpha-1 receptors, minimizing cardiovascular side effects. Dose: 100-500 mcg injections every 3-5 minutes. Crucial: Monitor for hypertension, tachycardia, and headache. | The standard next step if aspiration/irrigation with saline fails to achieve detumescence. |
| 3 | Surgical Shunting | This is a last-resort option for priapism lasting >24-48 hours that is refractory to the above measures. It involves creating a fistula to allow blood to bypass the occluded veins. • Peripheral Shunt: (e.g., Winter shunt) – creating a connection between the glans and corpora. • Proximal Shunt: A more major surgical procedure. | Reserved for refractory, prolonged priapism. Carries a high risk of permanent erectile dysfunction. |
4. Prevention of Recurrence (Stuttering Priapism)
For patients with frequent stuttering episodes, proactive management is key.
- First-Line Pharmacological Prevention:
- Oral Alpha-Agonists: Pseudoephedrine (30-60 mg at bedtime) is often used as a first-line preventative measure.
- Hormonal Therapy: Diethylstilbestrol (DES) or Gonadotropin-Releasing Hormone (GnRH) agonists can be effective but have significant side-effect profiles (e.g., gynaecomastia, impaired fertility) and are used under specialist haematology guidance.
- Hydroxycarbamide (Hydroxyurea): This mainstay of SCD management reduces the frequency of all VOCs, including priapism, by increasing fetal haemoglobin (HbF) levels.
- Patient Education: Patients should be advised to:
- Maintain good hydration.
- Empty their bladder fully before sleep.
- Take regular pseudoephedrine at night if prescribed.
- Seek urgent medical attention if an erection lasts >2 hours.
Summary for Clinical Practice
- Think: Priapism in SCD = Urological Emergency.
- Avoid: PDE5 inhibitors, intracavernosal agents, and alpha-blockers.
- Act:TIME IS TISSUE. Manage aggressively using a step-wise approach:
- Immediate: Strong analgesia, IV fluids.
- If >4 hours: Escalate to corporal aspiration and irrigation.
- If refractory: Use intracavernosal phenylephrine.
- Last Resort: Consider surgical shunt for prolonged, refractory cases.
- Prevent: For recurrent episodes, discuss pseudoephedrine and hydroxycarbamide with the haematology team.
